[go: up one dir, main page]

FI962985A - Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi - Google Patents

Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi Download PDF

Info

Publication number
FI962985A
FI962985A FI962985A FI962985A FI962985A FI 962985 A FI962985 A FI 962985A FI 962985 A FI962985 A FI 962985A FI 962985 A FI962985 A FI 962985A FI 962985 A FI962985 A FI 962985A
Authority
FI
Finland
Prior art keywords
pct
active substances
preparation
oral pharmaceutical
pharmaceutical form
Prior art date
Application number
FI962985A
Other languages
English (en)
Swedish (sv)
Other versions
FI116880B (fi
FI962985A0 (fi
Inventor
Walter Mueller
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI962985A0 publication Critical patent/FI962985A0/fi
Publication of FI962985A publication Critical patent/FI962985A/fi
Application granted granted Critical
Publication of FI116880B publication Critical patent/FI116880B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI962985A 1994-01-27 1996-07-26 Menetelmä oraalisen lääkemuodon valmistamiseksi, jossa on kantaja happamalle vaikuttavalle aineelle FI116880B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4402379A DE4402379C2 (de) 1994-01-27 1994-01-27 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung
DE4402379 1994-01-27
PCT/EP1994/004082 WO1995020394A1 (de) 1994-01-27 1994-12-08 Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung
EP9404082 1994-12-08

Publications (3)

Publication Number Publication Date
FI962985A0 FI962985A0 (fi) 1996-07-26
FI962985A true FI962985A (fi) 1996-07-26
FI116880B FI116880B (fi) 2006-03-31

Family

ID=6508812

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962985A FI116880B (fi) 1994-01-27 1996-07-26 Menetelmä oraalisen lääkemuodon valmistamiseksi, jossa on kantaja happamalle vaikuttavalle aineelle

Country Status (22)

Country Link
US (1) US5858344A (fi)
EP (1) EP0741574B1 (fi)
JP (1) JP3701971B2 (fi)
KR (1) KR100439311B1 (fi)
AT (1) ATE218371T1 (fi)
AU (1) AU697353B2 (fi)
CA (1) CA2182417C (fi)
CZ (1) CZ291006B6 (fi)
DE (2) DE4402379C2 (fi)
DK (1) DK0741574T3 (fi)
ES (1) ES2177622T3 (fi)
FI (1) FI116880B (fi)
HU (1) HU223317B1 (fi)
IL (1) IL112435A (fi)
MY (1) MY113340A (fi)
NO (1) NO963143L (fi)
NZ (1) NZ277777A (fi)
PL (1) PL315619A1 (fi)
PT (1) PT741574E (fi)
SK (1) SK97296A3 (fi)
WO (1) WO1995020394A1 (fi)
ZA (1) ZA95638B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
EP2561766B1 (en) 2006-11-07 2018-01-17 The Procter and Gamble Company Fiber containing compositions and methods of making and using same
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
CN117440977A (zh) 2021-06-07 2024-01-23 国立大学法人筑波大学 高分子化丙戊酸及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
ATE22804T1 (de) * 1982-03-01 1986-11-15 Efamol Ltd Pharmazeutische zusammensetzung.
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Also Published As

Publication number Publication date
CA2182417A1 (en) 1995-08-03
NO963143L (no) 1996-09-24
FI116880B (fi) 2006-03-31
ES2177622T3 (es) 2002-12-16
FI962985A0 (fi) 1996-07-26
JPH09511488A (ja) 1997-11-18
HU9602041D0 (en) 1996-09-30
DE59410133D1 (de) 2002-07-11
PL315619A1 (en) 1996-11-25
IL112435A0 (en) 1995-03-30
NO963143D0 (no) 1996-07-26
CZ291006B6 (cs) 2002-11-13
MY113340A (en) 2002-01-31
CA2182417C (en) 2007-04-17
EP0741574A1 (de) 1996-11-13
ATE218371T1 (de) 2002-06-15
NZ277777A (en) 1997-01-29
WO1995020394A1 (de) 1995-08-03
CZ221396A3 (en) 1997-01-15
AU697353B2 (en) 1998-10-01
SK97296A3 (en) 1997-04-09
ZA95638B (en) 1995-10-25
PT741574E (pt) 2002-11-29
IL112435A (en) 1999-01-26
US5858344A (en) 1999-01-12
DE4402379A1 (de) 1995-08-03
HU223317B1 (hu) 2004-05-28
DK0741574T3 (da) 2002-09-23
JP3701971B2 (ja) 2005-10-05
HUT74434A (en) 1996-12-30
DE4402379C2 (de) 1997-09-25
KR970700505A (ko) 1997-02-12
EP0741574B1 (de) 2002-06-05
AU1312795A (en) 1995-08-15
KR100439311B1 (ko) 2005-08-17

Similar Documents

Publication Publication Date Title
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
FI971776A (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
TR199800019T1 (xx) Trombosit topaklanmas�n� �nleyici yeni maddeler.
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
PT809488E (pt) Preparacoes solidas de substancias activas****************
FI951468A0 (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FR2671086B1 (fr) Peptides opiouides, leur procede de preparation, et composition pharmaceutique contenant ces peptides.
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
FI962985A (fi) Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi
NO174032C (no) Fremgangsmåte for fremstilling av en legemiddel-polymer-matriks innbefattende dimenhydrinat som en aktiv bestanddel
DE69733268D1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
ATE179422T1 (de) Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
FR2729575B1 (fr) Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif de type glycosaminoglycane anionique de basse masse moleculaire
FR2663329B1 (fr) Composes aromatiques amines, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2803521B1 (fr) Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose
AU628492B2 (en) Improvements in chemical compounds
JO1881B1 (en) Formula II for multi unit disc calibration
DE69313535D1 (de) N-Benzoylaminosäurederivate, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zur deren Herstellung
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
FR2666335B1 (fr) Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116880

Country of ref document: FI

MM Patent lapsed